Patent US923614A successfully refreshed from Google Patents.
Patent US4087920A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4882234A Expired / Lapsed US ⏱️ 0.0 years remaining

Storage-stable porphin compositions and a method for their manufacture

Assignee: Healux Inc
•
Filing: 1986-11-12
•
Granted: 1989-11-21
•
Expires: 2006-11-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Carboxyhydroxyporphin compounds such as hematoporphyrin exhibit instability upon warming. However, if this warming is extended and carried out in solution in the presence of a buffer so as to constitute a moderate temperature heat-treatment, a new composition of matter results which contains as much at 95% or more of an ester-linked oligomeric porphin-based material which is exceedingly storage-stable. This composition has superior activity as a photoimaging and photodynamic therapy agent. This process and the products it produces are disclosed. The oligomer products so formed can be formulated into pharmaceutical compositions for use in neoplastic tissue photoimaging and in photodynamic therapy of neoplastic tissues.

Inventors

  • 👤 Jan-Ji Lai
  • 👤 Kevin M. Smith
  • 👤 Bruce W. McCaul

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 11:20
CPC Classifications
C; C07; C07D; C07D487/00; C07D487/22; A; A61; A61K; A61K41/00; A61K41/0057; A61K41/0071; C07D519/00

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 89 words
A process for preparing a storage-stable carboxyhydroxyporphin-based product, said carboxyhydroxyporphin having from one to three inclusive carboxys and from one to three inclusive hydroxys per porphin ring, which process comprises the step of heat-treating a pH 5 to pH 9 buffered aqueous solution of said carboxyhydroxyporphin at a temperature of from 60° C. to 120° C. for a time in the range of from about 5 to about 100 hours sufficient to form a product in which at least about 80% of the carboxyhydroxyporphin is a storage-stable porphinbased oligomer.
Claim 2
Dependent Claim 89 words
A process for preparing a storage-stable carboxyhydroxyporphin-based product, said carboxyhydroxyporphin having from one to three inclusive carboxys and from one to three inclusive hydroxys per porphin ring, which process comprises the step of heat-treating a pH 5 to pH 9 buffered aqueous solution of said carboxyhydroxyporphin at a temperature of from 60° C. to 120° C. for a time in the range of from about 5 to about 100 hours sufficient to form a product in which at least about 80% of the carboxyhydroxyporphin is a storage-stable porphinbased oligomer.
Claim 3
Dependent Claim 11 words
The process of claim 1 wherein the carboxyhydroxyporphin comprises a carboxyhydroxychlorin.
Claim 4
Dependent Claim 11 words
The process of claim 1 wherein the carboxyhydroxyporphin comprises a carboxyhydroxyporphyrin.
Claim 5
Dependent Claim 82 words
A process for preparing a storage-stable hematoporphyrin-based product which process comprises the step of heat-treating a buffered pH 5 to pH 9 aqueous solution comprising at least about 0.1% by weight of a hematoporphyrin compound at a temperature of from about 60° C. to about 120° C. for a period in the range of from about 5 hours to about 100 hours adequate to yield a product in which at least about 80% of the hematoporphyrin compound is a storage-stable hematoporphyrin-based oligomer.
Claim 6
Dependent Claim 82 words
A process for preparing a storage-stable hematoporphyrin-based product which process comprises the step of heat-treating a buffered pH 5 to pH 9 aqueous solution comprising at least about 0.1% by weight of a hematoporphyrin compound at a temperature of from about 60° C. to about 120° C. for a period in the range of from about 5 hours to about 100 hours adequate to yield a product in which at least about 80% of the hematoporphyrin compound is a storage-stable hematoporphyrin-based oligomer.
Claim 7
Dependent Claim 12 words
The process of claim 4 wherein the hematoporphyrin compound comprises hematoporphyrin derivative.
Claim 8
Dependent Claim 84 words
A process for preparing a storage-stable hematoporphyrin-based product which process comprises the step of heat-treating a buffered pH 5 to pH 9 aqueous solution comprising from about 0.1% to about 2.5% by weight of hematoporphyrin at a temperature in the range of from about 75° C. to about 125° C. for a period in the range of from about 5 hours to about 100 hours adequate to yield a product in which at least about 80% of the hematoporphyrin is a storage-stable hematoporphyrin oligomer.
Claim 9
Dependent Claim 84 words
A process for preparing a storage-stable hematoporphyrin-based product which process comprises the step of heat-treating a buffered pH 5 to pH 9 aqueous solution comprising from about 0.1% to about 2.5% by weight of hematoporphyrin at a temperature in the range of from about 75° C. to about 125° C. for a period in the range of from about 5 hours to about 100 hours adequate to yield a product in which at least about 80% of the hematoporphyrin is a storage-stable hematoporphyrin oligomer.
Claim 10
Dependent Claim 14 words
The storage-stable carboxyhydroxyporphin oligomer product which is formed by the process of claim 1.
Claim 11
Dependent Claim 13 words
The storage-stable hematoporphyrin-based product which is formed by the process of claim 4.
Claim 12
Dependent Claim 13 words
The storage-stable hematoporphyrin-based product which is formed by the process of claim 5.
Claim 13
Dependent Claim 13 words
The storage-stable hematoporphyrin-based product which is formed by the process of claim 6.
Claim 14
Dependent Claim 18 words
A storage-stable carboxyhydroxyporphin-based pharmaceutical preparation comprising the product of claim 7 in a pharmaceutically acceptable injectable liquid carrier.
Claim 15
Dependent Claim 18 words
A storage-stable hematoporphyrin-based pharmaceutical preparation comprising the product of claim 8 in a pharmaceutically acceptable injectable liquid carrier.

References Cited (Backward Citations)

WO1984001382A1 Cited
US4649151A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-11-20 1993-05-22 1993-11-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-11-20 1997-05-22 1997-11-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-11-20 2001-05-22 2001-11-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag